SCHEMBL16998630

SCHEMBL16998630

CC1(C)CCC(C)(C)c2cc(CCN)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26B1 Q9NR63 4/20 0.51
CYP26A1 O43174 4/20 0.51
RXRA P19793 3/20 0.50
RXRB P28702 1/20 0.50
RXRG P48443 1/20 0.50
TAAR1 Q96RJ0 8/20 0.44
RARA P10276 2/20 0.43
RARB P10826 1/20 0.43
RARG P13631 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ATM Q13315 1/20 0.42
CYP3A4 P08684 1/20 0.42
PNMT P11086 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
ADRB2 P07550 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897524 0.83 CYP26B1 (0.53) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL11240978 0.81 CYP26B1 (0.51) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL4365965 0.81 CYP26B1 (0.55) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL6909472 0.80 CYP26B1 (0.50) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL15614968 0.79 KDM4E (0.40) TAAR1KDM4EATMCYP3A4PNMT
SCHEMBL4668411 0.79 CYP26B1 (0.52) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL7142134 0.79 CYP26B1 (0.49) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL3176733 0.79 RXRA (0.54) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL8795908 0.77 CYP26B1 (0.51) CYP26B1CYP26A1RXRARXRBRXRG
SCHEMBL15614940 0.77 TAAR1 (0.41) TAAR1KDM4EATMCYP3A4PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170170413-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-06-15 US disclosed
US-20170170413-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-06-15 US disclosed
WO-2015117718-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2015-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170413-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 CYP26B1 4528/4885CYP26A1 4110/4885RXRA 3738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.